include anorexia, bruxism, cranial abdominal pain, melena, signs of localized or generalized peritonitis, anemia, and death.
In adult cattle, suggested risk factors include abomasal lymphoma, stress from periparturient disease, diets high in carbohydrates, and use of nonsteroidal anti-inflammatory drugs. 4 Cattle admitted to veterinary hospitals often have a combination of these risk factors, and thus are predisposed to either having ulceration at admission or developing ulceration during hospitalization. One of the challenges of diagnosing and managing abomasal ulceration is the lack of sensitive and specific definitive diagnostic tests. Presence of melena, positive fecal occult blood tests, and typical clinical signs of bruxism and cranial abdominal pain are suggestive of abomasal ulceration. Thus, empirical treatment often is recommended as preventative or presumptive therapy.
Treatment of gastric ulceration in other species includes increasing gastric pH by use of PO alkalinizing agents or suppression of gastric acid production. The use of PO alkalinizing agents such as magnesium hydroxide and PO gastric acid suppressants including histamine type-2 receptor antagonists (H 2 RA) and proton pump inhibitors (PPI) has been studied in pre-ruminant calves. [5] [6] [7] These agents have variable efficacy in increasing abomasal pH in pre-ruminants. Administration of PO therapies may be ineffective in adult cattle because of the buffering and diluting effect of the rumen, unpredictable bioavailability, and delivery to the abomasum. 8 Limitations of parenteral administration of H 2 RA or PPI include the need for IV access, frequent administration, relatively large doses required, and associated cost.
Famotidine is an H 2 RA that competitively inhibits histamine binding to the H 2 -receptor on the basolateral membrane of the parietal cells, and thus decreases stimulation of the H 1 /K 1 ATPase pump at the luminal surface of the cell, which decreases acid secretion. It is used in humans with gastric or duodenal ulceration, as well as in those with gastroesophageal reflux disease. 9 Dosage rates in dogs have been suggested at 0.5 mg/kg IV q12h 10 and in horses at 0.2-0.4 mg/kg IV q6h-q8h. 11 Evidence for parental administration of gastric acid suppressants in adult cattle is lacking, although anecdotal descriptions of a variety of treatments are available. 4, 12 The dosage rate and frequency of administration chosen for our study utilized the upper end of the dosage for horses (q8h) to be able to detect an effect, if any, with a feasible time for sampling. We hypothesized that the abomasal outflow of adult cattle receiving IV famotidine will have a higher pH compared to the abomasal outflow of cattle treated with saline control. The objectives of our study were to: (1) assess the effect of a single dose of famotidine administered at a dosage of 0.4 mg/kg IV on the pH of abomasal outflow of adult cattle; (2) assess the effect of famotidine administered at a dosage of 0.4 mg/kg IV on the pH of abomasal outflow of adult cattle when administered as 3 doses q8h to mimic clinical treatment; and (3) to describe serum concentrations and pharmacokinetic parameters of famotidine in adult cattle.
| M A TE RI A L S A ND M E TH ODS

| Animals
This study was a randomized 2-way cross-over clinical trial utilizing 4
adult Angus steers fitted previously with surgically implanted duodenal cannulae placed orad to the biliary and pancreatic ducts. The steers were approximately 34 months of age and weighed 800 6 24.22 kg.
They were determined to be healthy based on clinical examination before the study, with no previous history of ulceration. They were housed in tie-stall stanchions for the 2 consecutive 48-hour sampling periods. The steers were fed 2.5 kg per head of an equal mixture of whole corn and pelleted soybean hulls twice daily at approximately 0700 and 1900 hours, starting 5 days before and during the study.
Steers also were offered ad libitum alfalfa hay and water. All animal procedures were approved by the University of Missouri Institutional Animal Care and Use Committee (ACUC) Protocol #8331. The interval between the single dose and multiple dose studies was 22
| Famotidine administration
hours. After a 34-hour washout period from the last treatment, the opposite treatment was administered and the study was repeated.
Time 0 represents the time period immediately preceding administration of either famotidine or saline control, and ranged from 2 to 4 hours after feeding concentrate. 
| Single dose study
| Multiple dose study
| Blood sampling
Whole blood samples were obtained after 20 mL of blood and hepari- 
| Drug concentration determination and pharmacokinetic analysis
Famotidine was quantified in bovine serum by liquid chromatographytandem mass spectrometry using a previously published method 13 If the second sample had a pH that was > 0.25 units more acidic than the initial sample, the new sample pH value was recorded. Any samples that had a pH > 5.0, or had gross contamination with bile or mucus were recorded, but not included in data analysis because they were considered an inaccurate reflection of abomasal outflow pH.
| Abomasal outflow pH statistical analysis
For abomasal outflow pH, a mixed model analysis with commercial software (SAS Version 9.4; SAS Institute Inc, Cary, North Carolina) was used. The MIXED procedure was used with treatment, sampling hour, and treatment 3 hour as the fixed effects and steer and period as random effects in the model. Least square means were separated using least significant difference and analyzed using analysis of variance.
P < .05 was considered statistically significant.
| R E SU LTS
The treatment 3 sampling hour interaction affected abomasal outflow pH for both a single dose and multiple doses of famotidine (P < .001). (famotidine; P < .001). The pH of outflow in the control group was less at 9 hours than at hours 1, 4, and 12 (P .04). Otherwise, the outflow pH of the control group did not change over time (P > .10).
Serum famotidine concentrations with respect to time after a single administration are summarized in Table 1 and shown in Figure 5 .
Measured serum famotidine concentrations from spiked serum separator tubes were 93%-95% of the concentrations measured in serum tubes without the silicone plug at all concentrations studied.
Pharmacokinetic parameters after administration of a single dose of famotidine are summarized in Table 2 No adverse clinical effects were observed in the steers for the duration of study period, based on lack of clinical abnormalities such as changes in fecal consistency, appetite, attitude, and physical examination findings at the conclusion of the study. time. 17 The presence of tachyphylaxis is clinically important when recommending dosing interval or frequency. 15 Previous reports describing use of other H 2 RA in ruminants have been published. In 1 report, abomasal pH increased for 1 hour after administration of ranitidine (6.6 mg/kg IM) in cattle. 12 Other studies have reported a dose-dependent effect of PO cimetidine and ranitidine in pre-ruminant calves. 5 The effect of IV ranitidine has been investigated in sheep with abomasal cannulae, indicating that a dosing interval of every 8-12 hours is most effective. 18 That study, however, also found that sheep receiving ranitidine had increased total serum protein and increased serum creatinine concentrations, increased aspartate aminotransferase activity, and decreased serum pepsinogen concentration, indicating safety concerns for this agent in sheep. 18 Drugs that increase gastric pH above 3.0 for up to 75% of a 24-hour period may be associated with healing of gastric or duodenal ulcers in humans. 19 When administered as a single dose, famotidine significantly increased the abomasal outflow pH compared to the controls for up to 4 hours, from a baseline of 4.26 6 0.81 pretreatment to a high of 6.016 0.18 at 2 hours post-administration of famotidine.
When administered every 8 hours, as has been clinically recommended, the greatest difference between control-and famotidine-treated cattle occurred 2 hours after administration of the first dose. However, the 2 groups were only different for 7 hours of a 24-hour period, which
equates to approximately 30% of the day. This is less than the observed 48.9% of a 24-hour period in dogs treated with famotidine (0.5 mg/kg IV q12h) 10 and less than the 75% of the day recommended in humans. 19 This finding suggests that administering H 2 RA every 8 hours may not be cost-effective if there is no clinical effect, and perhaps may have the same duration of effect in a 24-hour period, if administered less frequently. These percentages are less than the suggested interval for treatment of humans, but the optimal degree of gastric acid suppression has not been clearly defined in veterinary species, including cattle.
Our study reports higher pH values obtained for fluid from duodenal cannulae as compared with studies with direct luminal abomasal fluid measurement in calves and adult cattle, either from direct cannulation or abomasocentesis, 5, 7, 8, 20, 21 which may be a consequence of backflow of biliary and pancreatic secretions and mucus production by 
